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Synapse loss occurs early in Alzheimer’s disease (AD) patients and animal models.
Alterations at synaptic level are a major morphological correlate of the memory
deficits and related symptoms of AD. Given the predominant roles of synaptic AMPA
receptors (AMPARs) in excitatory synaptic transmission in the brain, changes in their
dynamic regulation are also implicated in the pathophysiology of AD. Here, we used
immunolocalization techniques to analyze the expression and subcellular distribution of
AMPARs in the hippocampal region of APP/PS1 mouse model of AD. Immunoblots
and histoblots revealed that the total amount of AMPARs and their regional expression
pattern in the hippocampus was similar in APP/PS1 mice and in age-matched wild type
mice. At the ultrastructural level, two synapse populations were examined using SDS-
digested freeze-fracture replica labeling in the stratum radiatum in mice: (i) on spines of
CA1 pyramidal cells; and (ii) on randomly found dendritic shafts of CA1 interneurons.
While 1- and 6-months-old APP/PS1 mice exhibited no change, we observed a
significant reduction at 12 months in AMPAR density at synapses in both pyramidal
cells and interneurons, compared to wild-type. This reduction of AMPARs in dendritic
spines was accompanied by a significant increase in AMPAR subunit proteins identified
in intracellular compartments. Our data demonstrate an age-dependent reduction of
synaptic AMPARs in APP/PS1 mice, which may contribute to impaired learning and
memory at later stages of AD.
Keywords: AD mouse model, hippocampus, electron microscopy, AMPA receptors, Alzheimer’s disease
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INTRODUCTION
Alzheimer’s disease (AD) is a devastating neurodegenerative
disorder characterized by progressive cognitive deficit and
memory loss. Characteristic pathological features of AD are
amyloid-β (Aβ) plaques and neurofibrillary tangles of aggregated
hyperphosphorylated tau proteins in the brain (Bloom, 2014).
Whilst this pathology is widespread throughout the brain, the
entorhinal cortex and hippocampus are the most affected areas
in AD (Hyman et al., 1984). In the hippocampus, CA1 pyramidal
cells are the neurons most vulnerable to neurodegeneration, with
a prominent loss of dendritic spines (West et al., 2000, 2004)
and eventual cell death, but interneurons are also targeted in
AD (Villette and Dutar, 2017). Soluble Aβ oligomers reduce the
number of dendritic spines and impair glutamatergic synaptic
transmission (Mucke and Selkoe, 2012).
Glutamatergic synaptic neurotransmission is regulated by
the abundance and molecular composition of the glutamate
receptor subtypes expressed at synapses by specific neuron types.
The main targets of glutamatergic input in the hippocampus
are the dendritic spines of pyramidal cells or granule cells
and the dendritic shafts of interneurons (Spruston, 2008).
Ionotropic glutamate receptors mediate the fast component of
glutamatergic responses, mostly consisting of AMPA (α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid) and NMDA (N-
methyl-D-aspartate) receptors (Hollmann and Heinemann,
1994; Traynelis et al., 2010). AMPA receptors (AMPARs) are
tetrameric complexes composed of homomeric or heteromeric
combinations of four (GluA1–4) subunits, encoded by distinct
genes, GRIA1–GRIA4 (Traynelis et al., 2010). The majority
of AMPARs in the hippocampus consist of heteromeric
combinations of GluA1, GluA2, and GluA3 subunits (Keinänen
et al., 1990). Immunoelectron microscopy using post-embedding
immunogold labeling has been used to investigate AMPARs at
excitatory synapses in the hippocampus in normal brains (Nusser
et al., 1998; Petralia et al., 1999; Takumi et al., 1999; Racca et al.,
2000). However, until now, these high-resolution techniques have
not been applied for the identification of AD-related pathological
changes in AMPAR numbers and densities.
Given the central role of AMPARs in learning and memory,
their disfunction likely contribute to synaptic and memory
deficits associated with AD. Consistent with this idea, previous
studies have shown that Aβ can contribute to the down-
regulation of synaptic transmission as a consequence of AMPAR
internalization (Almeida et al., 2005; Hsieh et al., 2006; Gu
et al., 2009; but see Whitcomb et al., 2015). Previous studies
using autoradiography, in situ hybridization, immunoblots or
immunohistochemical techniques produced conflicting results
regarding the expression of AMPARs in AD brains. Some studies
have shown that the distributions of subunits (GluA1, GluA2/3,
GluA4) in the hippocampus of AD brains are similar to control
brains (Hyman et al., 1994). In contrast, other studies suggested
that GluA2 and GluA2/3 are reduced, but GluA1 is unchanged
(Carter et al., 2004). Furthermore, earlier studies also proposed
a reduction in GluA1 levels (Pellegrini-Giampietro et al., 1994),
or consistent decrease in all four AMPAR subunits (Ikonomovic
et al., 1995, 1997; Aronica et al., 1997; Thorns et al., 1997;
Wakabayashi et al., 1999). However, these changes were not
investigated at the level of individual neurons or synapses.
At present, it is not clear whether AMPARs are altered at
all excitatory synapses in the hippocampus of AD brains. They
may also be selectively disrupted at specific postsynaptic sites or
neuron types. To clarify these possibilities in the hippocampal
CA1 region, we employed immunoblots, histoblots, and high-
resolution quantitative immunocytochemical techniques, with
specific focus on the hippocampal regions of APP/PS1 mice. Here
we provide compelling new evidence for a reduction in synaptic
AMPARs in pyramidal cells and interneurons of the hippocampal
CA1 region in the APP/PS1 AD mouse model, with a parallel
increase in intracellular AMPAR population.
MATERIALS AND METHODS
Animals
Male APP/PS1 mice (RRID:IMSR_MMRRC:034832)
were obtained from the Jackson Laboratory1 and
expressed Mo/Hu APP695swe construct in conjunction
with the exon-9-deleted variant of human presenilin 1
[Tg(APPswe,PSEN1dE9)85Dbo/Mmjax] (Jankowsky et al.,
2001, 2004). The “control” wild type (WT) mice were age-
matched littermates without the transgene. The following ages
were selected for analysis: (i) no sign of pathology (1 month),
(ii) first signs of Aβ deposition (6 months) (Jankowsky et al.,
2004), and (iii) onset of memory deficits with severe synapse
loss and widespread Aβ deposition (12 months) (Garcia-Alloza
et al., 2006; Gimbel et al., 2010). For all ages and genotypes,
mice were used as follows for the experiments: Immunoblot
(4), Histoblot (4), SDS-digested freeze-fracture replica labeling
(SDS-FRL) (4) and pre-embedding immunogold experiments
(3). All mice were maintained at the Animal House Facility of
the University of Castilla-La Mancha (Albacete, Spain) in cages
of two or more mice, on a 12 h light/12 h dark cycle at 24◦C
and received food and water ad libitum. Care and handling of
animals prior to and during experimental procedures were in
accordance with Spanish (RD 1201/2015) and European Union
regulations (86/609/EC), and all protocols and methodologies
were approved by the local Animal Care and Use Committee.
For immunoblotting and histoblotting, animals were deeply
anesthetized by intraperitoneal injection of ketamine/xylazine 1:1
(ketamine, 100 mg/Kg; xylazine, 10 mg/Kg), the hippocampus
was dissected, frozen rapidly in liquid nitrogen and stored at
−80◦C. For immunohistochemistry experiments at both the
light microscopic and electron microscopic level, using the
pre-embedding immunogold technique, animals were firstly
deeply anesthetized by intraperitoneal injection of ketamine-
xylazine 1:1 (ketamine, 100 mg/Kg; xylazine, 10 mg/Kg) and
then transcardially perfused with ice-cold fixative containing 4%
(w/v) paraformaldehyde with 0.05% (v/v) glutaraldehyde in 0.1
M phosphate buffer (PB, pH 7.4) for 15 min. After perfusion,
brains were removed and immersed in the same fixative for 2 h
or overnight at 4◦C. Tissue blocks were washed thoroughly in
1https://www.jax.org/strain/005864
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0.1 M PB. Coronal sections (60 µm thickness) were cut using a
Vibratome (Leica V1000). For SDS-FRL, see below.
Antibodies and Chemicals
For SDS-FRL, we used a new in-house generated rabbit anti-
GluA1–4 (pan-AMPA) receptor polyclonal antibody (D160)
(Supplementary Figure 1), whose preparation and purification
were carried out by following and updating protocols used
to prepare a previous in-house rabbit pan-AMPAR antibody
(Nusser et al., 1998; Pickard et al., 2000). In brief, the antibody
was raised against a glutathione S-transferase (GST) fusion
protein that contained the 58 extracellular amino-acid residues
(724–781) that preceded the last membrane-spanning segment of
GluR1flop [GSTGluA1flop(724−781)] and affinity purified with a
maltose-binding protein fusion protein with the identical amino
acid residues used for immunization. The aa sequence is highly
conserved in GluA1–4 and therefore the obtained antibody is
expected to react with all AMPAR subunit proteins (Pickard et al.,
2000; Supplementary Figure 1).
For histoblot and immunoblots, we used a guinea pig
pan-GluA1–4 receptor antibody (GP-Af580; aa. 717–754 of
mouse AMPA; Frontier Institute Co., Japan). The antibody
characteristics have been described previously (Fukaya et al.,
2006). For the pre-embedding immunogold technique, we used
a polyclonal rabbit antibody anti-GluA2/3 (AB1506; Chemicon,
Temecula, CA, United States). These antibodies were raised
against synthetic peptides derived from intracellular C-terminal
sequences of the GluA2 and GluA3 subunits (Wenthold et al.,
1992). A monoclonal anti-α-tubulin antibody (DM1A; ref CP06)
was obtained from Millipore (Millipore Corporation, Burlington,
MA, United States). For double-SDS-FRL, we used a mouse
monoclonal antibody against the GluN1 subunit of NMDA
receptor (MAB363, Millipore Bioscience Research Reagents).
The characteristics and specificity of GluN1 was characterized
previously (Siegel et al., 1994; Iwasato et al., 2000; Masugi-
Tokita et al., 2007; Szabadits et al., 2011). While the guinea pig
AMPAR antibody worked well for histoblots and immunoblots,
it produced relatively weak labeling in SDS-FRL. Therefore, we
used rabbit anti-GluA1–4 antibodies for SDS-FRL.
The following secondary antibodies were used: goat anti-
mouse IgG-horseradish peroxidase (1: 2,000; Santa Cruz
Biotechnology, Santa Cruz, CA, United States), goat anti-
rabbit IgG-horseradish peroxidase (1: 15,000; Pierce, Rockford,
United States), alkaline phosphatase (AP)-goat anti-mouse IgG
(H + L) and AP-goat anti-rabbit IgG (H + L) (1: 5,000;
Invitrogen, Paisley, United Kingdom), anti-rabbit IgG conjugated
to 10 nm gold particles and anti-mouse IgG conjugated to
5 nm gold particles (1: 100; British Biocell International, Cardiff,
United Kingdom).
Immunoblots
Hippocampi were homogenized in 50 mM Tris Base, pH
7.4, and protease inhibitor cocktail (Thermo Fisher Scientific,
Pierce, Rockford, United States) with a motorized pestle (Sigma-
Aldrich). The homogenized tissue was initially centrifuged
10 min at 1,000 × g at 4◦C and the supernatant was further
centrifuged 30 min at 12,000 × g (Centrifuge 5415R, Eppendorf,
Hamburg, Germany) at 4◦C. The resulting pellet, containing the
membrane extracts, was resuspended in 50 mM Tris-Cl, pH 7.4,
and protease inhibitor cocktail (Thermo Fisher Scientific, Pierce,
Rockford, United States). The protein content of each membrane
extract was determined by the BCA protein assay kit (Thermo
Fisher Scientific). Twenty five micrograms of membrane protein
was loaded onto sodium dodecyl sulfate polyacrylamide (7.5%)
gels (SDS/PAGE) in sample buffer [0.05 M Tris pH 6.8, 2% (w/v)
SDS, 10% (v/v) glycerol, 0.05% (v/v) β-mercaptoethanol, and
0.001% (w/v) bromophenol blue]. The proteins were transferred
to PVDF membranes using a semidry transfer system, followed
by immunolabeling with anti-GluA1–4 (1:1,000) and anti-α-
tubulin (1:1,000) antibodies. Protein bands were visualized and
detected after application of a mouse IgG kappa binding protein
coupled to horseradish peroxidase (1:2,000 dilution) and using
the enhanced chemiluminescence (ECL) blotting detection kit
(SuperSignal West Dura Extended Duration Substrate, Pierce,
Rockford, United States). Blots were captured and quantified by
densitometry using a LAS4000 MINI (Fujifilm, Japan).
Histoblotting
The regional distribution of AMPARs was analyzed in rodent
brains, using the histoblot technique (Molnár, 2016; Aguado
and Luján, 2019). Briefly, horizontal cryostat sections (10 µm)
from mouse brain were overlayed with nitrocellulose membranes
moistened with 48 mM Tris-base, 39 mM glycine, 2% (w /v)
sodium dodecyl sulfate and 20% (v /v) methanol for 15 min at
room temperature (∼20◦C). After blocking in 5% (w /v) non-
fat dry milk in phosphate-buffered saline for 1 h, nitrocellulose
membranes were treated with DNase I (5 U /mL), washed
and incubated in 2% (w /v) sodium dodecyl sulfate and
100 mM β-mercaptoethanol in 100 mM Tris–HCl (pH 7.0) for
60 min at 45◦C to remove any remaining tissue residues. After
extensive washing, the blots were reacted with affinity-purified
anti-GluA1–4 antibodies (0.5 mg /mL) in blocking solution
overnight at 4◦C. The bound primary antibodies were detected
with alkaline phosphatase-conjugated anti-rabbit IgG secondary
antibodies (Molnár, 2016; Aguado and Luján, 2019). To compare
the expression levels of AMPARs between the wild type and
APP/PS1 mice and at all ages, all nitrocellulose membranes were
processed in parallel, and with the same incubation time for each
reagent was used for the antibody. Digital images were acquired
by scanning the nitrocellulose membranes using a desktop
scanner (HP Scanjet 8300). Image analysis and processing were
performed using the Adobe Photoshop software (Adobe Systems,
San Jose, CA, United States) as described previously (Martín-
Belmonte et al., 2019). For both, a series of primary and
secondary antibody dilutions and incubation times were used to
optimize the experimental conditions for the linear sensitivity




Immunohistochemical reactions at the electron microscopic level
were carried out using the pre-embedding immunogold and
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the SDS-FRL methods as described earlier (Tanaka et al., 2005;
Luján et al., 2018).
Pre-embedding Immunogold Method
Briefly, free-floating sections obtained from WT and APP/PS1
and three ages (1, 6, and 12-months) were incubated in
parallel in 10% (v/v) NGS diluted in TBS. Sections were then
incubated in anti-GluA2/3 antibodies (3–5 µg/mL diluted in
TBS containing 1% (v/v) NGS), followed by incubation in goat
anti-rabbit IgG coupled to 1.4 nm gold (Nanoprobes Inc., Stony
Brook, NY, United States). Sections were post-fixed in 1% (v/v)
glutaraldehyde and washed in double-distilled water, followed
by silver enhancement of the gold particles with an HQ Silver
kit (Nanoprobes Inc.). Sections were then treated with osmium
tetroxide [1% (w/v) in 0.1 M phosphate buffer], block-stained
with uranyl acetate, dehydrated in graded series of ethanol and
flat-embedded on glass slides in Durcupan (Fluka) resin. Regions
of interest were cut at 70–90 nm using an ultramicrotome
(Reichert Ultracut E, Leica, Austria) and collected on single
slot pioloform-coated copper grids. Ultrastructural analyses were
performed in a JEOL-1010 electron microscope.
SDS-FRL Technique
Animals were anesthetized with sodium pentobarbital (50 mg/kg,
i.p.) and perfused transcardially with 25 mM PBS for 1 min,
followed by perfusion with ice-cold fixative containing 2% (w/v)
paraformaldehyde in 0.1 M phosphate buffer (PB) for 12 min.
After perfusion, brains were immediately removed from the
skull, and then the hippocampi were dissected and cut into
coronal slices (130 µm) using a Microslicer (Dosaka, Kyoto,
Japan) in 0.1 M PB. Next, hippocampal slices containing the CA1
region were trimmed out of the slices, and immersed in graded
glycerol of 10–30% (v/v) in 0.1 M PB at 4◦C overnight. Slices
were frozen using a high-pressure freezing machine (HPM010,
BAL-TEC, Balzers). Slices were then fractured into two parts
at −120◦C and replicated by carbon deposition (5 nm thick),
platinum (60◦ unidirectional from horizontal level, 2 nm), and
carbon (15–20 nm) in a freeze-fracture replica machine (BAF060,
BAL-TEC, Balzers). Replicas were transferred to 2.5% (w/v) SDS
and 20% (w/v) sucrose in 15 mM Tris-Cl buffer (pH 8.3) for
18 h at 80◦C with shaking to dissolve tissue debris. The replicas
were washed three times in 50 mM Tris-buffered saline (TBS,
pH 7.4), containing 0.05% (w/v) bovine serum albumin (BSA),
and then blocked with 5% (w/v) BSA in the washing buffer
for 1 h at room temperature. Next, the replicas were washed
and reacted with the following primary antibodies: (1) pan-
GluA1–4 antibody raised in rabbit (7.3 µg/mL), or (2) mixture
of the pan-GluA1–4 and mouse monoclonal antibody against
the GluN1 subunit of NMDA receptor (10 µg/mL; Millipore
Bioscience Research Reagents), diluted in 25 mM TBS containing
1% (w/v) BSA overnight at 15◦C. Following three washes in 0.05%
BSA in TBS and blocking in 5% (w/v) BSA/TBS, replicas were
incubated in goat anti-rabbit (for pan-GluA1–4) IgGs coupled to
5 nm gold particles (1:30; British BioCell Research Laboratories)
diluted in 25 mM TBS containing 5% (w/v) BSA overnight
at room temperature. In the double-labeling protocols, replicas
were first reacted with the pan-GluA1–4 antibody and then
anti-rabbit secondary antibody conjugated to 10 nm gold particle,
followed by incubation with the GluN1 antibody and then anti-
mouse secondary antibody conjugated to 5 nm gold particle.
When the primary antibody was omitted, no immunoreactivity
was observed. After immunogold labeling, the replicas were
immediately rinsed three times with 0.05% BSA in TBS, washed
twice with distilled water, and picked up onto grids coated with
pioloform (Agar Scientific, Stansted, Essex, United Kingdom)
and examined with an electron microscope (Hitach H-7650)
equipped with a digital camera (Quemesa, EM SIS).
Quantification and Analysis of SDS-FRL
Data
The labeled replicas were examined using a transmission electron
microscope (JEOL-1010) and images captured at magnifications
of 80,000× or 100,000×. All antibodies used in this study were
visualized by immunoparticles on the exoplasmic face (E-face),
consistent with the extracellular location of their epitopes. Non-
specific background labeling for anti-AMPAR was estimated by
counting immunogold particles on the protoplasmic face (P-
face) surfaces in wild type mice. This value was on average 2.3
immunoparticles/µm2, and was not subtracted from values for
specific labeling given the low value. Digitized images were then
modified for brightness and contrast using Adobe PhotoShop
CS5 (Mountain View, CA, United States) to optimize them for
quantitative analysis.
Number and Density of AMPAR Immunoparticles in
Excitatory Synapses
We determined the number of AMPAR immunoparticles at
excitatory synapses present in dendritic spines of CA1 pyramidal
cells in the stratum radiatum and in the dendritic shafts of
interneurons located in the stratum radiatum of the CA1 region
of the hippocampus, in both wild type and APP/PS1 mice
and at all three ages. For this aim, we used the software
GPDQ (Gold Particle Detection and Quantification) developed
recently to perform automated and semi-automated detection
of gold particles present in a given compartment of neurons
(Luján et al., 2018). The vast majority of the spines in
stratum radiatum arise from pyramidal cells, thus we refer
to them as pyramidal cell spines. Dendritic shafts receiving
multiple excitatory and inhibitory synapses are considered to
originate from interneurons. For identification of neuronal
compartment in the SDS-FRL samples, oblique dendrites were
identified based on their small diameter and the presence of
at least one emerging spine from the dendritic shaft. Dendritic
spines were considered as such if: (i) they emerged from a
dendritic shaft, or (ii) they opposed an axon terminal. Dendritic
spines are smaller in size compared to dendritic shafts of
interneurons. Given these differences in size, excitatory synapses
in spines are normally observed with a concave shape, while
in interneurons they have a more flattened morphology. Axon
terminals were identified based on: (i) the presence of an active
zone (AZ) facing a postsynaptic density (PSD), recognized by
an accumulation of intramembrane particles (IMPs), on the
opposing exoplasmic-face (E-face) of a spine or dendrite; or
(ii) the presence of synaptic vesicles on their cross-fractured
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portions. Non-specific background labeling was measured on
P-face structures surrounding the measured E-faces.
Quantitative analysis of immunogold labeling for
AMPAR subunits was performed on excitatory postsynaptic
specializations indicated by the presence of intramembrane
particle (IMP) clusters on the exoplasmic face (E-face) (Harris
and Landis, 1986). One of the advantages of the SDS-FRL
technique is that the whole synaptic specialization of excitatory
synapses is immediately visible over the surface of neurons. The
outline of postsynaptic specialization (IMP clusters) is manually
demarcated by connecting the outermost IMP particles, and the
area of synaptic sites is measured using the software GPDQ.
Immunogold particles for AMPARs were regarded as synaptic
labeling if they were within demarcated IMP clusters and those
located in the immediate vicinity within 30 nm from the edge
of the IMP clusters, i.e., the potential distance between the
immunogold particles and antigens. The number of immunogold
particles was counted in both complete and incomplete (partially
fractured) postsynaptic membrane specialization. An incomplete
postsynaptic membrane specialization was considered as such
when it was partially cut by a fracture, but contained at least 30
IMPs. AMPAR-positive excitatory synapses that were co-labeled
with more than two immunoparticles for GluN1 were included
as synaptic IMP clusters in the analysis to make sure we were
dealing with glutamatergic synaptic contacts. As densities of
immunogold labeling for the pan-GluA1–4 antibody obtained
from complete and incomplete synapses were not significantly
different, they were pooled. The density of the immunoparticles
for AMPARs in each synaptic site was calculated by dividing the
number of the immunoparticles by the area of the demarcated
IMP clusters. Measurements were performed in three animals,
and results were pooled due to the fact that the density for
immunogold particles was not significantly different in the
different animals. Then, we calculated the average density
across synapses. Immunoparticle densities are presented
as mean± SEM.
Finally, it is worth mentioning that neuronal loss is only
observed adjacent to plaques in the APP/PS1 mouse model2.
Accordingly, our quantitative analysis was performed in Aβ
plaque-free regions of the hippocampus to avoid the destroyed
tissue in dystrophic neurites adjacent to Aβ plaques (Alonso-
Nanclares et al., 2013), and also carried out systematically on
identified excitatory synapses, which were similar in numbers
(n) and total surface areas between the two genotypes. Thus,
the density values expressed as immunoparticles/µm2 in the
APP/PS1 mice at 12 months of age represent genuine reduction of
AMPARs in different types of CA1 excitatory synapses, regardless
of any possible neuronal and/or synaptic loss.
Controls
To test method specificity in the procedures for electron
microscopy, the primary antibodies were either omitted or
replaced with 5% (v/v) normal serum of the species of the
primary antibody, resulting in total loss of the signal. For the pre-
embedding technique, labeling patterns were also compared with
2https://www.alzforum.org/research-models/
those obtained by calbindin (polyclonal rabbit anti-calbindin D-
9k CB9; Swant, Marly, Switzerland); only the antibodies against
GluA1–4 consistently labeled excitatory synapses.
Data Analysis
To avoid observer bias, we performed blinded experiments for
immunoblots and immohistochemistry prior to data analysis.
Statistical analyses were performed using GraphPad Prism
(San Diego, CA, United States) and data were presented as
mean ± SEM unless indicated otherwise. Statistical significance
was defined as p < 0.05. The statistical evaluation of the
immunoblots was performed using the Student-Fisher t-test,
with Levene’s test for homogeneity of variance and Shapiro-
Wilks normality test. The application of Levene’s test indicated
that variances are equal, and the application of Shapiro-Wilks
test indicated that distributions were normal. To compute
SEM error bars, five blots were measured from each animal.
The statistical evaluation of the immunogold densities in the
mouse model was performed using the two-way ANOVA test
and Bonferroni post-hoc test. Correlations were assessed using
Pearson’s correlation test. Finally, statistical evaluation of the
frequency of immunogold measured with pre-embedding and
frequency of co-localization measured with immunofluorescence
were performed using student-t test with Holm-Sidak correction,
following the application of Shapiro-Wilks test indicating that
distributions were normal.
RESULTS
AMPAR Expression Patterns Are Similar
in Control and APP/PS1 Mice
Using the guinea pig anti-GluA1–4 antibody in conventional
histoblots (Aguado and Luján, 2019), we determined in first
place whether the expression of AMPAR was altered in the brain
of APP/PS1 mice at different ages: 1 month (Figures 1A–C),
6 months (Figures 1D–F), and 12 months (Figures 1G–I). The
overall expression patterns of GluA1–4 was very similar in wild
type and APP/PS1 mice (Figures 1A–I). In wild type mice at all
three ages, the strongest GluA1–4 immunoreactivity was found
in the neuropil layers of the hippocampal formation, in the
superficial layers of neocortex, and in the cerebellar molecular
layer (Figures 1A,D,G). Moderate labeling was found in deeper
layers of the neocortex, in the caudate putamen and thalamus
(Figures 1A,D,G). This expression pattern was very similar in the
brain of APP/PS1 mice at all ages (Figures 1B,E,H). Quantitative
analyses performed to compare the protein densities for all ages
revealed that GluA1–4 immunoreactivities were similar between
wild type and APP/PS1 mice (Figures 1C,F,I).
Given that one of the most vulnerable brain regions affected in
AD is the hippocampus (West et al., 2000, 2004), we next focused
on this brain region to explore the laminar expression pattern
of AMPARs. GluA1–4 is widely expressed in all hippocampal
regions and dendritic layers at all ages of both wild type and
APP/PS1 mice (Figures 2A–I). In the CA1 and CA3 regions of
wild type mice, at all ages, GluA1–4 expression was moderate
to strong, with the strata oriens and lacunosum-moleculare
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FIGURE 1 | Regional expression of AMPARs in the brain in wild type and APP/PS1 mice. (A–I) Expression of GluA1–4 proteins was visualized using histoblots of
horizontal brain sections at 1, 6, and 12 months of age in wild type and APP/PS1 mice, using an affinity-purified anti-GluA1–4 antibody. AMPAR expression in
different brain regions was determined by densitometric analysis of the scanned histoblots (C,F,I). The highest level of AMPAR expression was detected in the
hippocampus (Hp), followed by the cerebellum (Cb), cortex (Cx), and septum (Sp). Lower expression levels were detected in the caudate putamen (CPu) and the
thalamus (Th). Densitometric analysis showed no differences in AMPAR expression in APP/PS1 mice compared to age-matched wild type controls. Error bars
indicate SEM. Scale bars: 0.2 cm.
showing the lowest and the stratum radiatum showing the
highest expression levels (Figures 2A,D,G). The stratum lucidum
in the CA3 region showed weak expression level throughout
(Figures 2A,D,G). In the dentate gyrus of wild type mice, GluA1–
4 immunolabeling was weak in the hilus and moderate in the
molecular layer (Figures 2A,D,G). The stratum pyramidale of
the CA1 and CA3 regions and the granule cell layer of the
dentate gyrus showed the weakest GluA1–4 immunolabeling
(Figures 2A,D,G). The labeling pattern of wild type mice was
similar to that of APP/PS1 mice at all ages (Figures 2B,E,H).
Quantitative analyses of immunoreactivities performed at the
three ages confirmed that the expression levels of GluA1–4 in
all subfields and dendritic layers analyzed was unchanged in
APP/PS1 mice compared to age-matched wild type controls
(Figures 2C,F,I).
We further evaluated the expression of GluA1–4 in the
hippocampus using immunoblots of membrane fractions, which
reaffirmed the data obtained using histoblots. The guinea pig
anti-GluA1–4 antibody revealed one immunoreactive band with
estimated molecular mass of ∼105 kDa (Figure 2J). The levels
of AMPAR proteins were unchanged in APP/PS1 compared
to age-matched wild type mice (Figures 2J,K). Overall, these
results indicate no detectable changes in overall expression of
AMPAR subunit proteins in APP/PS1 mice brains in any of the
investigated brain regions.
Synaptic AMPAR Distribution Is
Unaltered at 1 and 6 Months of Age in
APP/PS1 Mice Compared to Wild Type
Using the SDS-FRL method, we analyzed the distribution
and densities of AMPARs at excitatory synapses in the CA1
region of hippocampal sections obtained from 1, 6, and 12-
months of age wild type and APP/PS1 mice with an antibody
against highly conserved extracellular amino acid residues of
GluA1–4 (pan-AMPA). We showed that this antibody reacts
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FIGURE 2 | Hippocampal expression and distribution of AMPARs in wild type and APP/PS1 mice. (A–I) The expression of GluA1–4 proteins was visualized in
histoblots of horizontal brain sections at 1, 6, and 12 months of age in wild type and APP/PS1 mice using an affinity-purified anti-GluA1–4 antibody. The level of
AMPAR immunoreactivities in different hippocampal subfields and dendritic layers were determined by densitometric analysis of scanned histoblots. AMPAR
expression was moderate to strong in all dendritic layers of the CA1 and CA3 region and dentate gyrus, with the stratum radiatum (sr) of CA1 and CA3 showing the
highest expression level. Densitometric analysis showed no differences in AMPAR expression in APP/PS1 mice compared to age-matched wild type controls. Error
bars indicate SEM. Scale bars: 0.05 cm. (J,K) Immunoblots showing the expression of the AMPAR protein in the hippocampus at 1, 6, and 12 months of age in wild
type and APP/PS1 mice. Crude membrane preparations were probed with the anti-GluA1–4 antibody, which recognized a band with estimated molecular mass of
100 kDa. The developed immunoblots were scanned and densitometric measurements from five independent experiments (n = 4 brains) were averaged to compare
the protein densities for each age and experimental group. AMPAR immunoreactivities were normalized to the α-tubulin content of each sample and expressed as
pixel density. No differences were detected in APP/PS1 mice compared to age-matched wild type controls. Error bars indicate SEM.
selectively with all AMPAR subunits GluA1–4. Using the SDS-
FRL technique, clusters of IMPs on the E-face represent the
postsynaptic membrane specialization (PSDs) of glutamatergic
synapses (Tarusawa et al., 2009). Many IMP clusters were labeled
with anti-GluA1–4-linked immunogold particles in the CA1
region of the hippocampus.
We initially performed the ultrastructural analysis at 1
month (Figure 3) and 6 months of age (Figure 4), both
in wild type and APP/PS1 mice. In the four experimental
groups, immunoparticles for AMPARs were distributed over
the entire postsynaptic membrane specializations of spines and
interneurons with no apparent clustering (Figures 3A–F, 4A–E).
The number of functional AMPARs in individual IMP clusters
was plotted against the synaptic area and found to be
proportional (Figures 3G, 4F). The density of labeling varied
between synapses both in dendritic spines and interneurons
(Table 1), but we found no differences between APP/PS1 and
WT mice (Figures 3H,I, 4G,H). Overall, these results indicate no
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FIGURE 3 | Synaptic AMPARs in dendritic spines and interneurons of APP/PS1 mice at 1 month. (A–F) Electron micrographs of the hippocampus showing
immunoparticles for AMPARs at excitatory synaptic sites of dendritic spines of pyramidal cells and shafts of interneurons in the stratum radiatum of the CA1 region,
as detected using the SDS-FRL technique. Postsynaptic membrane specializations (IMP clusters, pseudo colored in blue for wild type and in red for APP/PS1 to aid
visualization) show strong immunoreactivity for AMPARs (10 nm gold particles), both in the wild type and in the APP/PS1 mice. Scale bars: (A–F), 200 nm.
(G) Scatter plots showing the correlation between surface areas of postsynaptic membrane specializations and numbers of gold particles labeling AMPARs in wild
type and APP/PS1 mice. (H) Histograms showing the distribution of densities of gold particles that label AMPARs of individual postsynaptic membrane
specializations in the stratum radiatum of the hippocampal CA1 region in wild type and APP/PS1 mice. (I) Quantitative analysis showing mean densities of AMPARs
in excitatory synapses in spines and interneurons in the stratum radiatum in wild type and APP/PS1 mice. No differences were detected in densities of AMPAR
immunoparticles in the spines (WT = 496 ± 23 immunoparticles/µm2; APP = 560 ± 22 immunoparticles/µm2) or interneurons (WT = 626 ± 53
immunoparticles/µm2; APP = 562 ± 29 immunoparticles/µm2) (Two-way ANOVA test and Bonferroni post-hoc test, p > 0.05).
changes in the synaptic localization of AMPAR subunit proteins
in APP/PS1 mice brains up until 6 months of age.
AMPAR Content of Excitatory Synapses
Is Reduced at 12 Months in APP/PS1
Mice
In the APP/PS1 mouse model of AD severe pathological damage
appears at 12 months of age (Garcia-Alloza et al., 2006). In wild
type mice, immunoparticles for AMPARs in dendritic spines
followed a similar synaptic pattern as at earlier ages, observed
over the postsynaptic membrane specializations (Figures 5A–
C). In contrast, fewer AMPAR immunoparticles were detected
in excitatory synapses of dendritic spines in APP/PS1 mice
(Figures 5D–F). The number of gold particles labeling AMPARs
was variable (Table 1), but proportional to the synaptic area
both in wild type (R = 0.74) and APP/PS1 (R = 0.66) mice
(p< 0.0001, Pearson’s correlation test) (Figure 5G). Quantitative
analyses revealed a reduction in the number and density of
AMPARs in excitatory synapses of dendritic spines. The number
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FIGURE 4 | Synaptic AMPARs in dendritic spines and interneurons of APP/PS1 mice at 6 months of age. (A–F) Electron micrographs of the hippocampus showing
immunoparticles for AMPARs at excitatory synaptic sites of dendritic spines of pyramidal cells and shafts of interneurons in the CA1 stratum radiatum, as detected
using the SDS-FRL technique at 6 months of age. Postsynaptic membrane specializations (IMP clusters, pseudo colored in blue for wild type and in red for APP/PS1
to aid visualization) show strong immunoreactivity for GluA1–4 (10 nm gold particles) both in the wild type and in the APP/PS1 mice. Scale bars: (A–E), 200 nm.
(F) Scatter plots showing the correlation between surface areas of postsynaptic membrane specializations and numbers of gold particles labeling AMPARs in wild
type and APP/PS1 mice. (G) Histograms showing the distribution of densities of gold particles that label AMPARs of individual postsynaptic membrane
specializations in the hippocampal CA1 region in wild type and APP/PS1 mice. (H) Quantitative analysis showing mean densities of AMPARs in excitatory synapses
in spines and interneurons in the stratum radiatum in wild type and APP/PS1 mice. No differences were detected in densities of AMPAR immunoparticles in the
spines (WT = 443 ± 25 immunoparticles/µm2; APP = 505 ± 23 immunoparticles/µm2) or interneurons (WT = 494 ± 33 immunoparticles/µm2; APP = 421 ± 27
immunoparticles/µm2) (Two-way ANOVA test and Bonferroni post-hoc test, p > 0.05).
of AMPAR immunoparticles distributed in excitatory synapses
(n = 111) varied in the range of 2–81 with a median value of
19, but in APP/PS1 dendritic spines (n = 109) in the range
of 1–39 with a median value of 6 (Figure 5H and Table 1).
Although the density of labeling varied between synapses
(Figure 5I), we found a significant reduction in AMPAR levels
in APP/PS1 synapses (median = 245 immunoparticles/µm2)
compared to age-matched wild type controls (median = 459
immunoparticles/µm2) (Two-way ANOVA test and Bonferroni
post-hoc test, ∗∗∗∗p< 0.0001) (Figure 5I and Table 1).
Next, we performed ultrastructural analyses to determine
whether synaptic AMPARs are also altered in excitatory synapses
on interneurons (Figure 6). Similarly to 1 and 6 month
old mice, immunoparticles for AMPARs in interneurons at
12 months of age were observed over the postsynaptic membrane
specializations in wild type mice (Figures 6A–C), but were
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TABLE 1 | Number and density of gold particles for pan-AMPAR at different excitatory synapses in the CA1 stratum radiatum.
1 month 6 months 12 months
Spines Interneurons Spines Interneurons Spines Interneurons
WT
Excitatory synapses (n) 62 46 53 38 111 135
Median gold particles 18 53.5 10 18.5 19 22
Range 53–2 165–8 25–1 60–2 81–2 95–3
Density gold particles (µm2)
Mean (±SEM) 496.01 (±23.38) 637.84 (±40.58) 442.89 (±53.27) 494.09 (±33.23) 459.51 (±16.01) 395.70 (±13.70)
Median 487.62 658.88 434.46 504.09 458.96 385.40
Range 995.33–104.97 1235.35–189.89 912.28–38.58 951.47–67.80 883.93–62.44 748.40–98.40
APP/PS1
Excitatory Synapses (n) 66 34 62 37 109 173
Median gold particles 13.5 20 12 16 6 10
Range 40–4 57–7 30–1 87–3 39–1 55–1
Density gold particles (µm2)
Mean (±SEM) 560.19 (±22.13) 560.10 (±28.75) 504.60 (±53.27) 420.90 (±27.05) 261.13 (±13.01) 165.78 (±6.94)
Median 520.64 534.57 485.22 421.83 245.31 155.83
Range 1067.81–175.99 969.59–248.82 1077.67–109.78 831.80–69.81 826.88–28.45 462.54–16.57
Density values are provided in immunogold/µm2.
consistently fewer in APP/PS1 mice (Figures 6D–F). Although
the number of gold particles labeling AMPARs was variable
(Table 1), it was proportional to the synaptic area (Figure 6G).
In wild type mice, immunoparticles distributed in excitatory
synapses (n = 135) varied in the range of 3–95 with a median
value of 22, but in APP/PS1 dendritic spines (n = 173) in
the range of 1–55 with a median value of 10 (Figure 6H and
Table 1). When density of AMPAR labeling was analyzed, there
was a significant reduction of AMPARs in APP/PS1 synapses
(median = 156 immunoparticles/µm2) compared to age-matched
wild type (median = 385 immunoparticles/µm2) (Two-way
ANOVA test and Bonferroni post-hoc test, ∗∗∗∗p < 0.0001)
(Figure 6I and Table 1). In summary, these results indicate
a significant decrease in the synaptic localization of AMPAR
subunit proteins in APP/PS1 mouse brains at 12 months of age.
Increase of AMPARs in Intracellular
Compartments of Neurons in APP/PS1
Mice
We recently described using the same mouse model that whilst
the GABAB1 receptor protein expression is not altered, its
density is reduced in the plasma membrane and increased
at cytoplasmic sites in CA1 pyramidal cells (Martín-Belmonte
et al., 2019). To explore whether AMPARs undergo a similar
redistribution, their subcellular localization was investigated at
12 months using the quantitative pre-embedding immunogold
techniques on tissue blocks taken from the stratum radiatum
of the CA1 area (Figure 7). The anti-GluA1–4 antibody
recognizes extracellular domains of AMPAR subunits, and
this prevents the determination of their precise localization,
because when two neuronal compartments are close to each
other in the neuropil, the origin of immunoparticles cannot
always be established unambiguously. Therefore, we used an
anti-GluA2/3 antibody raised against the intracellular C-terminal
domain of AMPAR subunits, which are exposed on the
surface of intracellular compartments and identifiable using
immunolabeling (Bernard et al., 1997).
In both wild type and APP/PS1 mice, immunoreactivity for
GluA2/3 was detected in dendritic spines and shafts of CA1
pyramidal cells (Figures 7A–D), along their extrasynaptic plasma
membrane and also associated at intracellular sites. In wild
type mice, most immunoparticles for GluA2/3 were detected
along the extrasynaptic plasma membranes of pyramidal cells
(Figures 7A,B). In the APP/PS1 mice, however, immunoparticles
for AMPARs were more frequently detected intracellularly
(Figures 7C,D). This change in localization was demonstrated
using quantitative analyses (Figure 7E), which showed significant
differences in the total amount of plasma membrane-associated
vs. intracellular AMPAR labeling in CA1 pyramidal cells (Plasma
membrane: 61 ± 1.9% in wild type and 28 ± 3.6% in APP/PS1;
Intracellular: 39 ± 1.9% in wild type and 72 ± 3.6% in APP/PS1;
∗∗p < 0.01) (Student-T test and Holm-Sidak correction). This
change took place both in dendritic spines (Plasma membrane:
68 ± 0.4% in wild type and 38 ± 2.4% in APP/PS1; Intracellular:
32± 0.4% in wild type and 62± 2.4% in APP/PS1; ∗∗∗p< 0.001)
and dendritic shafts (Plasma membrane: 57 ± 2.6% in wild
type and 25 ± 3.5% in APP/PS1; Intracellular: 43 ± 2.6% in
wild type and 75 ± 3.5% in APP/PS1; ∗∗p < 0.01) (Student’s
T-test and Holm-Sidak correction) (Figure 7E). Given the low
expression of GluA2/3 in interneurons compared to pyramidal
cells, quantitative analysis was not feasible. To establish the
types of intracellular compartments in which AMPARs are
present, we performed double labeling immunofluorescence
with different marker proteins (Rab4, Rab5 and EEA1), and
found no differences in the co-localization pattern in the
APP/PS1 mice compared to age-matched wild type controls
(Supplementary Figure 3).
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FIGURE 5 | Reduced density of synaptic AMPARs in dendritic spines of APP/PS1 mice at 12 months. (A–F) Electron micrographs of the hippocampus showing
immunoparticles for AMPARs at excitatory synaptic sites of dendritic spines of pyramidal cells in the CA1 stratum radiatum, as detected using the SDS-FRL
technique. Postsynaptic membrane specializations (IMP clusters, pseudo colored in blue for wild type and in red for APP/PS1 to aid visualization) show strong
immunoreactivity for AMPARs (10 nm gold particles) in the wild type, while they show weaker immunoreactivity in the APP/PS1. Scale bars: (A–F), 200 nm.
(G) Scatter plots showing the correlation between surface areas of postsynaptic membrane specializations and numbers of gold particles labeling AMPARs in wild
type and APP/PS1 mice. (H) Histograms showing the distribution of densities of gold particles that label AMPARs of individual postsynaptic membrane
specializations in the hippocampal CA1 region in wild type and APP/PS1 mice. (I) Quantitative analysis showing mean densities of AMPARs in excitatory synapses in
spines in wild type and APP/PS1 mice. A significant reduction in the densities of AMPAR immunoparticles were detected in dendritic spines of APP/PS1 mice
(261 ± 13 immunoparticles/µm2) compared to age matched wild type (459 ± 16 immunoparticles/µm2) (Two-way ANOVA test and Bonferroni post-hoc test,
p < 0.0001).
DISCUSSION
In AD, hippocampal dysfunction is produced by synaptic failure
(Li and Selkoe, 2020), which leads to memory deficits. Changes
in AMPARs are involved in Aβ-related synaptic dysfunction and
pathophysiology of AD (reviewed by Keifer and Zheng, 2010;
Palop and Mucke, 2010; Whitehead et al., 2017). Here, using
biochemical and immunocytochemical techniques we examined
the expression of AMPARs, and found no change in GluA1–
4 protein expression in the APP/PS1 transgenic mouse model
of AD. However, using sensitive immunoelectron microscopic
techniques to analyze CA1 excitatory synapses in these mice,
we identified a reduction of synaptic AMPARs in two different
excitatory synapses and a parallel increase in GluA2/3 subunits
at intracellular sites. These differences in the density of AMPARs
were prominent at 12 months, but not detectable at earlier ages in
Frontiers in Aging Neuroscience | www.frontiersin.org 11 October 2020 | Volume 12 | Article 577996
fnagi-12-577996 October 2, 2020 Time: 11:42 # 12
Martín-Belmonte et al. Alzheimer’s Disease-Related Changes in AMPA Receptors
FIGURE 6 | Density of synaptic AMPARs in interneurons of APP/PS1 mice at 12 months. (A–F) Electron micrographs of the hippocampus showing immunoparticles
for AMPARs at synaptic sites of interneurons in the stratum radiatum of the CA1 region, as detected using the SDS-FRL technique. Postsynaptic membrane
specializations (IMP clusters, pseudo colored in blue for wild type and in red for APP/PS1 to aid visualization) show strong immunoreactivity for AMPARs (10 nm gold
particles) in the wild type, while they show weaker immunoreactivity in the APP/PS1. Scale bars: (A–F), 200 nm. (I) Quantitative analysis showing mean densities of
AMPARs in excitatory synapses in spines in wild type and APP/PS1 mice. A significant reduction in the densities of AMPAR immunoparticles were detected in
synaptic specialization of interneurons in APP/PS1 mice (166 ± 7 immunoparticles/µm2) compared to age matched wild type (396 ± 14 immunoparticles/µm2)
(Two-way ANOVA test and Bonferroni post-hoc test, p < 0.0001). (H) Histograms showing the distribution of densities of gold particles that label AMPARs in
SDS-FRL replicas of individual postsynaptic membrane specializations in the hippocampal CA1 region in wild type and APP/PS1 mice. (G) Scatter plots showing the
correlation between surface areas of postsynaptic membrane specializations and numbers of gold particles labeling AMPARs in wild type and APP/PS1 mice.
the APP/PS1 mouse model. These changes likely to be responsible
for pathological events in AD.
Expression of AMPARs in the
Hippocampus of APP/PS1 Mice
The expression of AMPARs has been extensively studied in
the brain of rodents (Boulter et al., 1990; Keinänen et al.,
1990; Petralia and Wenthold, 1992; Sato et al., 1993), and
there is substantial knowledge relating to their distribution and
regulation during development and aging (Jurado, 2018). In
the present study, we have shown by two different techniques
that expression levels of AMPARs proteins are not significantly
different in APP/PS1 mice with the progressive increase of Aβ
levels (Alonso-Nanclares et al., 2013) at different ages in the
hippocampus. Our data differs from other studies using different
mouse models of AD reporting down-regulation of the protein
for AMPAR subunits (Snyder et al., 2005; Baglietto-Vargas et al.,
2018; Li et al., 2019).
Previous studies using different techniques in human tissue
yielded inconsistent results (Harrison et al., 1990; Dewar et al.,
1991; Hyman et al., 1994; Pellegrini-Giampietro et al., 1994;
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FIGURE 7 | Increased intracellular distribution of GluA2/3 receptors in APP/PS1 mice at 12 months. Electron micrographs showing immunoparticles for GluA2/3
receptors in pyramidal cells of the CA1 region in wild type and APP/PS1 mice, as detected using a pre-embedding immunogold technique. (A,B) In wild type mice,
immunoparticles for GluA2/3 were found along the extrasynaptic plasma membrane (arrows) and intracellular sites (crossed arrows) of dendritic shafts (Den) and
spines (s) contacted by axon terminals (at). (C,D) In APP/PS1 mice, immunoparticles for GluA2/3 were more frequently detected at intracellular sites (crossed
arrows) and few immunoparticles along the plasma membrane (arrows). (E) Quantitative analysis showing that immunoparticles for GluA2/3 receptors were less
frequently observed along the extrasynaptic plasma membrane of dendrites and spines of CA1 pyramidal cells in APP/PS1 mice, but instead they more frequently
detected at intracellular sites in pyramidal cells. (Student-T test and Holm-Sidak correction, **p < 0.01; ***p < 0.001) Scale bars: (A,B,D), 1 µm; (C), 0.5 µm.
Ikonomovic et al., 1995, 1997; Aronica et al., 1997; Thorns et al.,
1997; Wakabayashi et al., 1999; Carter et al., 2004; Ginsberg et al.,
2012). Our study identified a clear reduction in AMPAR protein
levels in the hippocampus of AD patients (see Supplementary
Figure 2), consistent with the reported down-regulation in the
expression of GluA1 and GluA2 in AD (Martín-Belmonte et al.,
2019). This may be due to the use of different techniques, post-
mortem delays, brain weight and the age of the subjects, duration
of tissue storage, stage of AD or the variability in tissue sampling.
The discrepancy observed between protein expression levels
in the mouse model and in human tissue could be the result of
differences in brain organization or development of the disease
between humans and mice. It is also possible that such differences
are due to the fact that the APP/PS1 is an incomplete model of
AD. For instance, this model does not develop neurofibrillary
tangles, a typical pathologic alteration observed in AD human
patients (Irizarry et al., 1997). Alternatively, 12 months old
in the APP/PS1 model could be a relatively early stage of
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pathological evolution to be compared with the stages of AD
in human patients with severe AD neuropathology. Despite
the unaltered AMPAR protein expression levels in APP/PS1
mice, we explored the possibility that they may still undergo
changes in the synaptic localization vs. intracellular sites with
AD progression, as also recently described for GABAB receptors
(Martín-Belmonte et al., 2019).
Reduction of Synaptic AMPAR Levels in
APP/PS1 Mice: CA1 Pyramidal Cells
While previous studies used the post-embedding immunogold
technique to investigate numbers and densities of AMPARs
in the hippocampus (Nusser et al., 1998; Petralia et al., 1999;
Takumi et al., 1999; Racca et al., 2000), we utilized the highly
sensitive SDS-FRL method, with nearly one gold particle-one
functional channel sensitivity and proving to be an ideal tool
to study the high-resolution subcellular localization of surface-
localized molecules (Tanaka et al., 2005). Using this technique,
we were able to unravel the distribution of AMPARs in specific
CA1 excitatory synapses obtaining data about their density in
hippocampal samples displaying AD pathology, at a level of detail
and sensitivity never previously attained.
The efficacy of fast glutamatergic neurotransmission in
hippocampal neurons depends on the type and number of
ionotropic receptors in synapses, particularly AMPARs. Our
analysis revealed a great variability in the AMPAR content at
individual synapses, similarly to previous reports using post-
embedding immunogold techniques (Nusser et al., 1998; Petralia
et al., 1999; Takumi et al., 1999; Racca et al., 2000). Consistent
with these studies, the number of AMPAR immunoparticles
correlated with synaptic area in all experimental groups, but we
observed an age-dependent reduction in the density AMPARs
in Schaffer collateral synapses in APP/PS1 mice. We detected
significant decrease in the synaptic localization of AMPARs and
subsequent increase at cytoplasmic sites in CA1 pyramidal cell
spines and shafts at 12 months of age, but not earlier.
One important aspect to consider is that the size of
individual postsynaptic membrane specializations can affect
synaptic transmission. Previous studies have shown that CA1
dendritic spines have PSDs with size around 0.04–0.07 µm2
(Schikorski and Stevens, 1997; Shepherd and Harris, 1998). In
our work, the average size of PSDs that we found in the stratum
radiatum of CA1 pyramidal cells in wild type mice at the three
ages fell in that range (for instance, 0.046 ± 0.018 µm2 at
12 months), and was similar to the size observed previously
with similar techniques (Antal et al., 2008). The smaller average
size PSDs we encountered in APP/PS1 mice at 12 months is
in agreement with previous studies in the same animal model
and same age showing a higher proportion of spines with a
small head volume in the stratum radiatum of the CA1 region
(Merino-Serrais et al., 2011). The size of dendritic spines and
their PSD are key determinants of synaptic efficacy via control
of the distribution of AMPARs (Nusser et al., 1998; Takumi et al.,
1999; Matsuzaki et al., 2001).
Interestingly, internalization of AMPARs is required for the
induction of LTD (Beattie et al., 2000), a form of synaptic
plasticity significantly enhanced in animal models of AD
(Shankar et al., 2008). In addition, APP and soluble oligomeric
Aβ can induce the removal of surface AMPARs at excitatory
synapses, leading to synaptic depression and inhibition of LTP
(Walsh et al., 2002; Klyubin et al., 2005; Hsieh et al., 2006). In
relation to the effect of the observed unbalance between synaptic
and intracellular alterations, the reduction of surface AMPARs
and its abnormal trafficking may contribute to the memory
deficits in the AD mouse model. This may reflect changes in
synaptic plasticity, and this contribute to the memory deficits in
the AD mouse model used in this study (Trinchese et al., 2004).
Reduction of Synaptic AMPARs in
APP/PS1 Mice: Interneurons
Most studies of AD brains have concentrated on excitatory
neuronal functions, but compelling studies also implicate
impaired inhibition in the pathogenesis (Palop and Mucke,
2010; Verret et al., 2012; Hazra et al., 2013; Martinez-Losa
et al., 2018). Our results demonstrate a significant reduction
in the synaptic localization of AMPARs in excitatory synapses
onto dendritic shafts of interneurons in the APP/PS1 mouse
model, consistent with past evidence that interneurons and
the oscillatory network activities they regulate are altered in
AD (Palop and Mucke, 2016). Given the random fractures
in our replica samples (Masugi-Tokita and Shigemoto, 2007),
dendritic shafts of interneurons could not be followed back
to the parent cell body. Therefore, we could not exclude
the possibility that dendritic shafts establishing excitatory
synapses with different AMPAR contents represent dendrites
originating from distinct interneurons or just the same
interneuron receiving distinct inputs. Technical limitations
prevented unequivocal identification of the source of dendritic
shafts, but since the region of stratum radiatum we analyzed
was close to pyramidal cell bodies, these dendrites are
likely to arise from PV-positive cells (Nyíri et al., 2003),
which represent basket and axo-axonic cells whose axon
arborizations target the soma and the axon initial segment
of principal cells, respectively (Freund and Buzsáki, 1996;
Klausberger and Somogyi, 2008).
Upon post mortem examination, the hippocampi of AD
patients show a reduction in the number of PV-expressing
interneurons, as well as other subpopulations, in the
hippocampus (Brion and Résibois, 1994; Brady and Mufson,
1997). The significant reduction of synaptic AMPARs described
here in interneurons would lead to an aberrant weakening of
excitatory synapses, thus contributing to hyperexcitability and
deficits in synchrony. Interestingly, weakening of synapses due
to the reduction of AMPAR currents has been involved in the
impairment of network oscillatory activity (Caputi et al., 2012),
which is known to be essential for learning and memory. This too
contributes to cognitive abnormalities in AD (Verret et al., 2012;
Palop and Mucke, 2016). Therefore, improving the function of
interneurons may be of therapeutic benefit in AD.
In summary, this study is the first to report that reduction of
AMPARs takes place in excitatory synapses established on both
pyramidal cells and interneurons in APP/PS1 mice. Reductions
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in the receptors at synapses in both pyramidal cells and
interneurons are likely to contribute to the memory deficits
associated with AD. A deeper understanding of the subcellular
localization of AMPARs in the neurobiology of AD may elucidate
further mechanisms of the disease.
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